Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced today that its Chief Executive Officer, Dr. Kevin Rodan Levy, plans to attend HLTH Europe 2026, an international healthcare conference scheduled for June 15-18 in Amsterdam. The conference focuses on digital health, healthcare innovation, and emerging technologies, bringing together healthcare executives, innovators, investors, and technology leaders from global markets.
Dr. Levy's attendance is intended to support the Company's broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging technologies and market developments, and exploration of strategic relationships that may support the continued development and expansion of the Company's evolving digital health ecosystem. The Company believes that participation in major international healthcare conferences provides valuable opportunities to observe industry developments, strengthen professional networks, and advance its telehealth and artificial intelligence healthcare platform strategy.
Catalyst Crew Technologies is developing telehealth infrastructure and healthcare analytics platforms for emerging markets, with an initial emphasis on Latin America. The Company is actively executing its strategic transition into AI-enabled healthcare, pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. According to the press release, the Company is a development-stage enterprise and has not generated revenues from its newly announced business direction.
Dr. Levy stated: “As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning.”
The Company continues to advance the development of its telehealth platform infrastructure, artificial intelligence healthcare modules, and broader digital health strategy across Latin America and emerging markets. For more information, please visit https://catalystcrewai.com or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
